156 related articles for article (PubMed ID: 32739767)
21. The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S;
BMC Cancer; 2022 Jun; 22(1):610. PubMed ID: 35659273
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR; Mocellin S; Campana LG; Borgognoni L; Sestini S; Giudice G; Caracò C; Cordova A; Solari N; Piazzalunga D; Carcoforo P; Quaglino P; Caliendo V; Ribero S;
Ann Surg Oncol; 2018 Jan; 25(1):271-279. PubMed ID: 29067603
[TBL] [Abstract][Full Text] [Related]
23. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
[TBL] [Abstract][Full Text] [Related]
24. Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.
Piazzalunga D; Ceresoli M; Allievi N; Ribero S; Quaglino P; Di Lorenzo S; Corradino B; Campana LG; Mocellin S; Rossi CR;
Eur J Surg Oncol; 2019 May; 45(5):820-824. PubMed ID: 30527782
[TBL] [Abstract][Full Text] [Related]
25. Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients.
Fonseca IB; Lindote MVN; Monteiro MR; Doria Filho E; Pinto CAL; Jafelicci AS; de Melo Lôbo M; Calsavara VF; Bertolli E; Duprat Neto JP
Ann Surg Oncol; 2020 Oct; 27(11):4133-4140. PubMed ID: 32767223
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
[TBL] [Abstract][Full Text] [Related]
27. The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients.
Tejera-Vaquerizo A; Descalzo-Gallego MA; Traves V; Requena C; Bolumar I; Pla A; Nagore E
Eur J Dermatol; 2017 Oct; 27(5):487-495. PubMed ID: 28944755
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
29. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
[TBL] [Abstract][Full Text] [Related]
30. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
Fujisawa Y; Otsuka F;
Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
[TBL] [Abstract][Full Text] [Related]
31. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
32. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
33. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.
Fink AM; Holle-Robatsch S; Herzog N; Mirzaei S; Rappersberger K; Lilgenau N; Jurecka W; Steiner A
Melanoma Res; 2004 Apr; 14(2):141-5. PubMed ID: 15057045
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study.
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Descalzo-Gallego MA; Fierro MT; Quaglino P; Carrera C; Malvehy J; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Figueras MT; Ferrándiz C; Pascual I; Manzano JL; Sánchez-Lucas M; Giménez-Xavier P; Ferrandiz L; Nagore E
Int J Cancer; 2018 Feb; 142(3):641-648. PubMed ID: 28960289
[TBL] [Abstract][Full Text] [Related]
36. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
[TBL] [Abstract][Full Text] [Related]
38. Melanoma sentinel node biopsy and prediction models for relapse and overall survival.
Mitra A; Conway C; Walker C; Cook M; Powell B; Lobo S; Chan M; Kissin M; Layer G; Smallwood J; Ottensmeier C; Stanley P; Peach H; Chong H; Elliott F; Iles MM; Nsengimana J; Barrett JH; Bishop DT; Newton-Bishop JA
Br J Cancer; 2010 Oct; 103(8):1229-36. PubMed ID: 20859289
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Sondak VK; Thompson JF; Zager JS
Ann Surg Oncol; 2022 Sep; 29(9):5937-5945. PubMed ID: 35562521
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node biopsy in thin and thick melanoma.
Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
